What is Medical Properties Trust Inc's earnings per share (EPS)?

Medical Properties Trust Inc (MPT) reported diluted earnings per share of $-0.46 for fiscal year 2025. This represents a 88.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Medical Properties Trust Inc Financials

MPT

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Medical Properties Trust Inc (MPT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MPT FY2025 2026-04-22

Leverage has become the dominant business mechanic, as interest-heavy financing now absorbs much of the cash the asset base produces.

The accounting loss improved from -$2.4B in FY2024 to -$277M in FY2025, but that rebound did not repair debt service capacity. Operating cash flow was only $231M while interest expense reached $510M, so the income statement recovered faster than the cash economics of carrying the balance sheet.

Across FY2023-FY2025, the balance sheet became more levered even as the company was shrinking its asset footprint: debt to equity rose from 1.3x to 2.1x because losses eroded the equity cushion faster than liabilities came down. That means a larger share of the business now works to support creditors before it supports shareholders.

FY2025 cash increased to $541M from $332M, but that stronger liquidity sat alongside positive financing cash flow rather than a clear recovery in internal cash generation. In practical terms, near-term cash flexibility improved while self-funding strength remained limited relative to the size of the balance sheet.

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Medical Properties Trust Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Medical Properties Trust Inc's revenue declined 2.4% year-over-year, from $995.5M to $972.0M. This contraction results in a growth score of 43/100.

Leverage

Medical Properties Trust Inc has a moderate D/E ratio of 2.11. This balance of debt and equity financing earns a leverage score of 59/100.

Returns

Medical Properties Trust Inc generates a -6.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -49.9% the prior year.

Piotroski F-Score Neutral

4/9

Medical Properties Trust Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

-0.83x

For every $1 of reported earnings, Medical Properties Trust Inc generates $-0.83 in operating cash flow ($230.8M OCF vs -$277.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$972.0M

YoY-2.4%

5Y CAGR-4.9%

10Y CAGR+8.2%

Medical Properties Trust Inc generated $972.0M in revenue in fiscal year 2025. This represents a decrease of 2.4% from the prior year.

EBITDA

N/A

Net Income

-$277.0M

YoY+88.5%

Medical Properties Trust Inc reported -$277.0M in net income in fiscal year 2025. This represents an increase of 88.5% from the prior year.

EPS (Diluted)

$-0.46

YoY+88.6%

Medical Properties Trust Inc earned $-0.46 per diluted share (EPS) in fiscal year 2025. This represents an increase of 88.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$540.9M

YoY+62.7%

5Y CAGR-0.3%

10Y CAGR+10.7%

Medical Properties Trust Inc held $540.9M in cash against $9.7B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.33

YoY-28.3%

5Y CAGR-21.1%

10Y CAGR-9.3%

Medical Properties Trust Inc paid $0.33 per share in dividends in fiscal year 2025. This represents a decrease of 28.3% from the prior year.

Shares Outstanding

597M

YoY-0.6%

5Y CAGR+2.0%

10Y CAGR+9.7%

Medical Properties Trust Inc had 597M shares outstanding in fiscal year 2025. This represents a decrease of 0.6% from the prior year.

Margins & Returns

Gross Margin

90.7%

YoY-1.8pp

5Y CAGR-6.9pp

Medical Properties Trust Inc's gross margin was 90.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.8 percentage points from the prior year.

Operating Margin

N/A

Net Margin

-28.5%

YoY+213.6pp

5Y CAGR-63.0pp

10Y CAGR-60.1pp

Medical Properties Trust Inc's net profit margin was -28.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 213.6 percentage points from the prior year.

Return on Equity

-6.0%

YoY+43.9pp

5Y CAGR-11.9pp

10Y CAGR-12.7pp

Medical Properties Trust Inc's ROE was -6.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 43.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$23.4M

Medical Properties Trust Inc spent $23.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

N/A

MPT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$972.0M-2.4%	$995.5M+14.2%	$871.8M-43.5%	$1.5B-0.1%	$1.5B+23.6%	$1.2B
Cost of Revenue	$90.3M+21.8%	$74.2M-32.6%	$110.1M-34.3%	$167.4M+65.0%	$101.4M+236.6%	$30.1M
Gross Profit	$881.7M-4.3%	$921.4M+21.0%	$761.7M-44.6%	$1.4B-4.7%	$1.4B+18.4%	$1.2B
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$130.4M-2.5%	$133.8M-8.1%	$145.6M-9.3%	$160.5M+10.2%	$145.6M+10.6%	$131.7M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$510.4M+22.1%	$417.8M+1.6%	$411.2M+14.5%	$359.0M-2.3%	$367.4M+11.8%	$328.7M
Income Tax	$38.6M-12.4%	$44.1M+133.7%	-$130.7M-333.8%	$55.9M-24.4%	$73.9M+138.1%	$31.1M
Net Income	-$277.0M+88.5%	-$2.4B-333.1%	-$556.5M-161.7%	$902.6M+37.6%	$656.0M+52.0%	$431.4M
EPS (Diluted)	$-0.46+88.6%	$-4.02-332.3%	$-0.93-162.0%	$1.50+35.1%	$1.11+37.0%	$0.81

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$270.3M+13.8%	$237.5M-1.2%	$240.4M+7.4%	$223.8M-3.5%	$231.8M+2.7%	$225.8M-15.3%	$266.6M-1.8%	$271.3M
Cost of Revenue	N/A	N/A	N/A	$81.4M	N/A	N/A	N/A	$40.9M
Gross Profit	N/A	N/A	N/A	$142.4M	N/A	N/A	N/A	$230.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$24.6M-34.8%	$37.7M+44.0%	$26.2M-37.5%	$41.9M+47.1%	$28.5M-22.2%	$36.6M+3.7%	$35.3M+5.9%	$33.3M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$132.5M0.0%	$132.4M+2.1%	$129.7M+12.0%	$115.8M+14.1%	$101.5M-4.5%	$106.2M+4.7%	$101.4M-6.7%	$108.7M
Income Tax	$8.5M-21.8%	$10.9M+10.9%	$9.8M+3.9%	$9.4M-1.3%	$9.6M+5.9%	$9.0M-38.0%	$14.6M+33.0%	$10.9M
Net Income	$17.4M+122.3%	-$77.7M+21.0%	-$98.4M+16.8%	-$118.3M+71.4%	-$412.9M+48.5%	-$801.2M-149.9%	-$320.6M+63.4%	-$875.6M
EPS (Diluted)	N/A	$-0.13+18.8%	$-0.16+20.0%	$-0.20	N/A	$-1.34-148.1%	$-0.54+63.0%	$-1.46

MPT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$15.0B+4.9%	$14.3B-21.9%	$18.3B-6.9%	$19.7B-4.2%	$20.5B+21.9%	$16.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$540.9M+62.7%	$332.3M+32.9%	$250.0M+6.1%	$235.7M-48.7%	$459.2M-16.5%	$549.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.4B+9.9%	$9.5B-11.3%	$10.7B-3.5%	$11.1B-8.4%	$12.1B+27.3%	$9.5B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$9.7B+9.6%	$8.8B-12.1%	$10.1B-2.0%	$10.3B-9.0%	$11.3B+27.3%	$8.9B
Total Equity	$4.6B-4.7%	$4.8B-36.7%	$7.6B-11.2%	$8.6B+1.8%	$8.4B+15.0%	$7.3B
Retained Earnings	-$4.1B-13.1%	-$3.7B-276.5%	-$971.8M-935.7%	$116.3M+232.6%	-$87.7M-22.8%	-$71.4M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$15.0B+0.5%	$14.9B-1.5%	$15.2B+2.0%	$14.9B+3.9%	$14.3B-6.2%	$15.2B-5.9%	$16.2B-6.4%	$17.3B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$540.9M+36.4%	$396.6M-22.2%	$509.8M-24.3%	$673.5M+102.7%	$332.3M+20.6%	$275.6M-54.6%	$606.5M+170.4%	$224.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.4B+1.3%	$10.3B-0.5%	$10.3B+2.2%	$10.1B+6.7%	$9.5B-3.4%	$9.8B-2.1%	$10.0B-5.6%	$10.6B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$9.7B+0.8%	$9.6B-0.3%	$9.6B+1.9%	$9.5B+7.0%	$8.8B-4.0%	$9.2B-1.6%	$9.4B-7.2%	$10.1B
Total Equity	$4.6B-1.2%	$4.7B-3.6%	$4.8B+1.5%	$4.8B-1.5%	$4.8B-11.1%	$5.4B-12.1%	$6.2B-7.6%	$6.7B
Retained Earnings	-$4.1B-0.9%	-$4.1B-3.2%	-$4.0B-3.8%	-$3.8B-4.6%	-$3.7B-14.4%	-$3.2B-36.2%	-$2.3B-27.1%	-$1.8B

MPT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$230.8M-6.0%	$245.5M-51.5%	$505.8M-31.6%	$739.0M-9.0%	$811.7M+31.4%	$617.6M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$264.7M-120.1%	$1.3B+154.7%	$517.6M+30.7%	$396.1M+110.3%	-$3.9B-30.9%	-$2.9B
Financing Cash Flow	$228.1M+115.4%	-$1.5B-45.0%	-$1.0B+24.0%	-$1.3B-145.5%	$2.9B+110.4%	$1.4B
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$23.4M	N/A	N/A	$17.9M	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$160.1M+761.9%	$18.6M-64.1%	$51.7M+13375.8%	$384K-99.5%	$76.7M+29.5%	$59.2M+67.9%	$35.3M-52.6%	$74.3M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$7.9M+91.7%	-$95.1M-31.6%	-$72.3M+19.1%	-$89.4M-197.5%	$91.7M-36.2%	$143.8M-88.0%	$1.2B+1108.0%	-$119.3M
Financing Cash Flow	-$9.0M+73.9%	-$34.5M+77.7%	-$154.8M-136.3%	$426.3M+527.2%	-$99.8M+81.8%	-$548.1M+35.8%	-$853.5M-3966.4%	$22.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MPT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	90.7%-1.8pp	92.5%+5.2pp	87.4%-1.8pp	89.1%-4.3pp	93.4%-4.2pp	97.6%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-28.5%+213.6pp	-242.1%-178.3pp	-63.8%-122.3pp	58.5%+16.0pp	42.5%+7.9pp	34.5%
Return on Equity	-6.0%+43.9pp	-49.9%-42.6pp	-7.3%-17.8pp	10.5%+2.7pp	7.8%+1.9pp	5.9%
Return on Assets	-1.8%+15.0pp	-16.9%-13.8pp	-3.0%-7.6pp	4.6%+1.4pp	3.2%+0.6pp	2.6%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	2.11+0.3	1.83+0.5	1.32+0.1	1.20-0.1	1.34+0.1	1.21
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	63.6%	N/A	N/A	N/A	84.9%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	6.4%+39.1pp	-32.7%+8.2pp	-40.9%+11.9pp	-52.8%+125.2pp	-178.1%+176.7pp	-354.8%-234.5pp	-120.3%+202.4pp	-322.7%
Return on Equity	0.4%+2.1pp	-1.7%+0.4pp	-2.0%+0.4pp	-2.5%+6.1pp	-8.5%+6.2pp	-14.7%-9.5pp	-5.2%+7.9pp	-13.1%
Return on Assets	0.1%+0.6pp	-0.5%+0.1pp	-0.7%+0.2pp	-0.8%+2.1pp	-2.9%+2.4pp	-5.3%-3.3pp	-2.0%+3.1pp	-5.1%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	2.11+0.0	2.06+0.1	2.000.0	1.99+0.2	1.83+0.1	1.69+0.2	1.510.0	1.51
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is Medical Properties Trust Inc's annual revenue?

Medical Properties Trust Inc (MPT) reported $972.0M in total revenue for fiscal year 2025. This represents a -2.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Medical Properties Trust Inc's revenue growing?

Medical Properties Trust Inc (MPT) revenue declined by 2.4% year-over-year, from $995.5M to $972.0M in fiscal year 2025.

Is Medical Properties Trust Inc profitable?

No, Medical Properties Trust Inc (MPT) reported a net income of -$277.0M in fiscal year 2025, with a net profit margin of -28.5%.

How much debt does Medical Properties Trust Inc have?

As of fiscal year 2025, Medical Properties Trust Inc (MPT) had $540.9M in cash and equivalents against $9.7B in long-term debt.

What is Medical Properties Trust Inc's gross margin?

Medical Properties Trust Inc (MPT) had a gross margin of 90.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Medical Properties Trust Inc's net profit margin?

Medical Properties Trust Inc (MPT) had a net profit margin of -28.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Medical Properties Trust Inc pay dividends?

Yes, Medical Properties Trust Inc (MPT) paid $0.33 per share in dividends during fiscal year 2025.

What is Medical Properties Trust Inc's return on equity (ROE)?

Medical Properties Trust Inc (MPT) has a return on equity of -6.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Medical Properties Trust Inc's operating cash flow?

Medical Properties Trust Inc (MPT) generated $230.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Medical Properties Trust Inc's total assets?

Medical Properties Trust Inc (MPT) had $15.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Medical Properties Trust Inc buy back shares?

Yes, Medical Properties Trust Inc (MPT) spent $23.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Medical Properties Trust Inc have outstanding?

Medical Properties Trust Inc (MPT) had 597M shares outstanding as of fiscal year 2025.

What is Medical Properties Trust Inc's debt-to-equity ratio?

Medical Properties Trust Inc (MPT) had a debt-to-equity ratio of 2.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Medical Properties Trust Inc's return on assets (ROA)?

Medical Properties Trust Inc (MPT) had a return on assets of -1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Medical Properties Trust Inc's Piotroski F-Score?

Medical Properties Trust Inc (MPT) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Medical Properties Trust Inc's earnings high quality?

Medical Properties Trust Inc (MPT) has an earnings quality ratio of -0.83x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Medical Properties Trust Inc?

Medical Properties Trust Inc (MPT) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.